Reports
Sale
Global Effervescent Tablet Market Share: By Product: Medication, Supplement; By Type: Prescription Based, Over The Counter (OTC); By Application: Pharmaceutical, Dietary Supplements, Dental Products, Others; By End User: Hospitals, Homecare, Specialty Clinics, Others; By Distribution Channel; Regional Analysis; Supplier Landscape; 2024-2032
Global Effervescent Tablet Market Outlook
The global effervescent tablet market size was valued at USD 25.33 billion in 2023, driven by the increasing prevalence of chronic diseases across the globe. The market size is anticipated to grow at a CAGR of 8.7% during the forecast period of 2024-2032 to achieve a value of USD 53.66 billion by 2032.
Effervescent Tablet: Introduction
Effervescent tablets are the type of tablets that dissolve easily in water or other liquids while releasing carbon dioxide. The tablet breaks down easily hence it dissolves into a frothy or fizzy solution. With the use of these tablets, various other drugs can be consumed by consumers. Effervescent tablets come with various advantages. The tablets quickly deliver the dosage to the body as the medications are supplied in the form of a readily absorbed solution.
Effervescent tablets are manufactured by compressing powdered ingredients into a compact form, which is then packaged either in a blister pack or a hermetically sealed package that includes a desiccant in the cap. To use them, simply drop the tablets into water to create a solution. Alternatively, the powdered ingredients may be sold as effervescent powders or granulated and sold as effervescent granules.
Global Effervescent Tablet Market Analysis
The market is witnessing an increase in the number of research and development activities, which further aids the growth of the market. Major key players in the market are continuously working on developing novel drugs to enhance the health and lifestyle of patients. The innovation in the formulation of these tablets is also responsible for increasing global effervescent tablets market share. For example, effervescent products that quickly transform into beverages are beneficial for the environment as they decrease the use of plastics. The use of various formulations of materials also enhances the process of administration, further increasing the global effervescent tablets market growth.
The heavy investments in the development of innovative technologies and novel effervescent products are also expected to majorly boost market growth by providing market opportunities for manufacturers to develop new and innovative effervescent products.
Global Effervescent Tablet Market Segmentations
Market Breakup by Product
- Medication
- Supplement
Market Breakup by Type
- Prescription Based
- Over The Counter (OTC)
Market Breakup by Application
- Pharmaceutical
- Dietary Supplements
- Dental Products
- Others
Market Breakup by End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Market Breakup by Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Effervescent Tablet Market Overview
The growth of the market can be significantly attributed to the increasing prevalence of chronic diseases globally. These tablets are easy to use and only require a drop of water to make a solution. The increased demand for effervescent tablets is driven by various aspects, such as the pleasant taste, distribution more evenly, increased liquid intake, easy alternative to regular tablets, and simple and easy-to-measure. These tablets are even safe to consume comparatively. The easy availability of these tablets over various distribution channels is a major factor driving the global effervescent tablets market growth. For example, the availability of these tablets even as glucose tablets provides a quick energy boost. This acts as a major relief to chronic patients and thus boosts the market growth.
The increasing health awareness among people and rising disposable income have also shifted their focus towards healthy products, such as probiotics, vitamins, dietary supplements, and minerals, which further drives the global effervescent tablets market growth.
The widespread availability of effervescent products, such as dietary supplements to prevent diseases, and nutritional deficiencies and improve consumers' overall health and lifestyle, is a major factor fuelling the market growth. The production of new products and launches in the market is expected to drive the market growth further.
Geographically, North America is expected to dominate the market due to the presence of major key players. The increased healthcare expenditure is also expected to boost the growth of the regional market. The market is also driven by the increasing number of research and development activities in the region.
Global Effervescent Tablet Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Pfizer Inc.
- GSK plc
- Novartis AG
- Bayer AG
- Perrigo Company plc
- Reckitt Benckiser Group PLC
- Bristol-Myers Squibb Company
- CHIESI SAS
- Hermes Pharma
- S. G. Biopharm Pvt. Ltd
- Bliss GVS Pharma Limited
- Amerilab Technologies Inc.
- HERMES ARZNEIMITTEL
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Type |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Effervescent Tablet Market Overview
3.1 Global Effervescent Tablet Market Historical Value (2017-2023)
3.2 Global Effervescent Tablet Market Forecast Value (2024-2032)
4 Global Effervescent Tablet Market Landscape
4.1 Global Effervescent Tablet Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Effervescent Tablet Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Type
4.2.3 Analysis by Application
5 Global Effervescent Tablet Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Effervescent Tablet Market Segmentation
6.1 Global Effervescent Tablet Market by Product
6.1.1 Market Overview
6.1.2 Medication
6.1.3 Supplement
6.2 Global Effervescent Tablet Market by Type
6.2.1 Market Overview
6.2.2 Prescription Based
6.2.3 Over The Counter (OTC)
6.3 Global Effervescent Tablet Market by Application
6.3.1 Market Overview
6.3.2 Pharmaceutical
6.3.3 Dietary Supplements
6.3.4 Dental Products
6.3.5 Others
6.4 Global Effervescent Tablet Market by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Homecare
6.4.4 Specialty Clinics
6.4.5 Others
6.5 Global Effervescent Tablet Market by Distribution Channel
6.5.1 Market Overview
6.5.2 Hospital Pharmacy
6.5.3 Online Pharmacy
6.5.4 Retail Pharmacy
6.5.5 Others
6.6 Global Effervescent Tablet Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Effervescent Tablet Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Effervescent Tablet Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Effervescent Tablet Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Effervescent Tablet Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Effervescent Tablet Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Pfizer Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 GSK plc
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Novartis AG
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Bayer AG
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Perrigo Company plc
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Reckitt Benckiser Group PLC
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Bristol-Myers Squibb Company
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 CHIESI SAS
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Hermes Pharma
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 S. G. Biopharm Pvt. Ltd
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Bliss GVS Pharma Limited
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Amerilab Technologies Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 HERMES ARZNEIMITTEL
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
18 Global Effervescent Tablet Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 25.33 billion in 2023, driven by increasing clinical trials.
The market is anticipated to grow at a CAGR of 8.7% during the forecast period of 2024-2032, likely to reach a market value of USD 53.66 billion by 2032.
The increasing prevalence of chronic diseases and increasing health awareness among people are among the major factors driving the market growth.
The increased number of research and development activities, coupled with technological advancements, are major among trends influencing market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
The products include medication and supplements.
These tablets are available in over the counter and on-premises.
They find their applications in pharmaceuticals, dietary supplements, and dental products, among others.
End users in the market include hospitals, home care, and specialty clinics, among others.
End users in the market include hospitals, home care, and specialty clinics, among others.
Distribution channels include hospital pharmacies, online pharmacies, and retail pharmacies, among others.
Key players involved in the market are Pfizer Inc., GSK plc, Novartis AG, Bayer AG, Perrigo Company plc, Reckitt Benckiser Group PLC, Bristol-Myers Squibb Company, CHIESI SAS, Hermes Pharma, S. G. Biopharm Pvt. Ltd, Bliss GVS Pharma Limited, Amerilab Technologies Inc., and HERMES ARZNEIMITTEL.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER